Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease
Kevin Huynh,Wei Ling Florence Lim,Corey Giles,Kaushala S. Jayawardana,Agus Salim,Natalie A. Mellett,Adam Alexander T. Smith,Gavriel Olshansky,Brian G. Drew,Pratishtha Chatterjee,Ian Martins,Simon M. Laws,Ashley I. Bush,Christopher C. Rowe,Victor L. Villemagne,David Ames,Colin L. Masters,Matthias Arnold,Kwangsik Nho,Andrew J. Saykin,Rebecca Baillie,Xianlin Han,Rima Kaddurah-Daouk,Ralph N. Martins,Peter J. Meikle
DOI: https://doi.org/10.1038/s41467-020-19473-7
IF: 16.6
2020-11-10
Nature Communications
Abstract:Abstract Changes to lipid metabolism are tightly associated with the onset and pathology of Alzheimer’s disease (AD). Lipids are complex molecules comprising many isomeric and isobaric species, necessitating detailed analysis to enable interpretation of biological significance. Our expanded targeted lipidomics platform (569 species across 32 classes) allows for detailed lipid separation and characterisation. In this study we examined peripheral samples of two cohorts (AIBL, n = 1112 and ADNI, n = 800). We are able to identify concordant peripheral signatures associated with prevalent AD arising from lipid pathways including; ether lipids, sphingolipids (notably GM 3 gangliosides) and lipid classes previously associated with cardiometabolic disease (phosphatidylethanolamine and triglycerides). We subsequently identified similar lipid signatures in both cohorts with future disease. Lastly, we developed multivariate lipid models that improved classification and prediction. Our results provide a holistic view between the lipidome and AD using a comprehensive approach, providing targets for further mechanistic investigation.
multidisciplinary sciences